sixty-seven patients with favorable pathologic stage ( ps ) i and iia or b or iiia hodgkin 's disease were randomized to receive subtotal or total lymphoid irradiation ( stli/tli ) alone or involved field irradiation ( if ) plus six cycles of a novel adjuvant chemotherapy containing vinblastine , bleomycin , and methotrexate ( vbm ) .
C0019829
hodgkin 's disease
C0005740
bleomycin